CN101222935B - 免疫原性组合物 - Google Patents

免疫原性组合物 Download PDF

Info

Publication number
CN101222935B
CN101222935B CN200680023149.5A CN200680023149A CN101222935B CN 101222935 B CN101222935 B CN 101222935B CN 200680023149 A CN200680023149 A CN 200680023149A CN 101222935 B CN101222935 B CN 101222935B
Authority
CN
China
Prior art keywords
sugar
menc
carrier protein
conjugated
meny
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200680023149.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN101222935A (zh
Inventor
R·L·比曼斯
D·布特里奥
C·卡皮奥
P·德内尔
P·迪维维耶
J·普尔曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0513071.1A external-priority patent/GB0513071D0/en
Priority claimed from GB0515556A external-priority patent/GB0515556D0/en
Priority claimed from GB0524204A external-priority patent/GB0524204D0/en
Priority claimed from GB0526041A external-priority patent/GB0526041D0/en
Priority claimed from GB0526040A external-priority patent/GB0526040D0/en
Priority to CN201210028358.6A priority Critical patent/CN102526723B/zh
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority claimed from PCT/EP2006/006268 external-priority patent/WO2007000341A2/en
Publication of CN101222935A publication Critical patent/CN101222935A/zh
Publication of CN101222935B publication Critical patent/CN101222935B/zh
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN200680023149.5A 2005-06-27 2006-06-23 免疫原性组合物 Active CN101222935B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210028358.6A CN102526723B (zh) 2005-06-27 2006-06-23 免疫原性组合物

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
GBGB0513071.1A GB0513071D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0513069.5 2005-06-27
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0513071.1 2005-06-27
GB0515556A GB0515556D0 (en) 2005-07-28 2005-07-28 Immunogenic composition
GB0515556.9 2005-07-28
GB0524204.5 2005-11-28
GB0524204A GB0524204D0 (en) 2005-11-28 2005-11-28 Immunogenic composition
GB0526040A GB0526040D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
GB0526040.1 2005-12-21
GB0526041.9 2005-12-21
GB0526041A GB0526041D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
PCT/EP2006/006268 WO2007000341A2 (en) 2005-06-27 2006-06-23 Immunogenic composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201210028358.6A Division CN102526723B (zh) 2005-06-27 2006-06-23 免疫原性组合物

Publications (2)

Publication Number Publication Date
CN101222935A CN101222935A (zh) 2008-07-16
CN101222935B true CN101222935B (zh) 2015-07-29

Family

ID=34856207

Family Applications (4)

Application Number Title Priority Date Filing Date
CN200680023149.5A Active CN101222935B (zh) 2005-06-27 2006-06-23 免疫原性组合物
CN2006800311786A Active CN101247827B (zh) 2005-06-27 2006-06-23 疫苗生产方法
CN2006800233344A Active CN101208103B (zh) 2005-06-27 2006-06-23 免疫原性组合物
CN2006800230577A Active CN101208101B (zh) 2005-06-27 2006-06-23 免疫原性组合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
CN2006800311786A Active CN101247827B (zh) 2005-06-27 2006-06-23 疫苗生产方法
CN2006800233344A Active CN101208103B (zh) 2005-06-27 2006-06-23 免疫原性组合物
CN2006800230577A Active CN101208101B (zh) 2005-06-27 2006-06-23 免疫原性组合物

Country Status (7)

Country Link
CN (4) CN101222935B (no)
ES (1) ES2367918T5 (no)
FR (1) FR12C0060I2 (no)
GB (1) GB0513069D0 (no)
NO (1) NO2021022I1 (no)
UA (1) UA97233C2 (no)
ZA (3) ZA200710853B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE040914T4 (hu) * 2012-01-30 2019-05-28 Serum Institute Of India Pvt Ltd Immunogén készítmény
AU2013303826B2 (en) * 2012-08-16 2017-06-29 Pfizer Inc. Glycoconjugation processes and compositions
HUE052751T2 (hu) * 2016-11-25 2021-05-28 Glaxosmithkline Biologicals Sa Natív OMV-antigén konjugátumok és alkalmazásuk
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
CN115819616A (zh) * 2021-07-28 2023-03-21 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
JP4870895B2 (ja) * 2000-06-29 2012-02-08 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
EP1372707A1 (en) * 2001-04-06 2004-01-02 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖－蛋白结合疫苗
WO2004067030A2 (en) * 2003-01-30 2004-08-12 Chiron Srl Injectable vaccines against multiple meningococcal serogroups

Also Published As

Publication number Publication date
FR12C0060I1 (no) 2012-12-14
FR12C0060I2 (fr) 2017-01-06
NO2021022I1 (no) 2021-05-25
UA97233C2 (uk) 2012-01-25
ES2367918T5 (es) 2014-11-21
ES2367918T3 (es) 2011-11-10
CN101208103A (zh) 2008-06-25
ZA200710909B (en) 2009-04-29
ZA200710853B (en) 2009-04-29
CN101208101A (zh) 2008-06-25
CN101222935A (zh) 2008-07-16
CN101208101B (zh) 2013-01-02
CN101247827A (zh) 2008-08-20
CN101247827B (zh) 2013-07-17
ZA200711074B (en) 2009-07-29
CN101208103B (zh) 2013-04-24
GB0513069D0 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
CN103083657B (zh) 免疫原性组合物
CN101222935B (zh) 免疫原性组合物
AU2012203419B2 (en) Immunogenic composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant